Tag: Schizophrenia
Probiotic, Vitamin D Supplementation Tied to Benefits With Schizophrenia
Improvements seen in cognition, cholesterol, blood sugar, and C-reactive protein
Schizophrenia Linked to Increased Risk for Subsequent CVD Events
Association between schizophrenia and cardiovascular disease events more pronounced in women than men
Many People With Schizophrenia Have Stable Cognition Over 20 Years
However, neurocognitive declines are seen in others, which is tied to other poor outcomes
Intensive Meditation Intervention Aids Schizophrenia Symptoms
Significant improvements seen at eight months for positive symptoms and hallucinations, delusions
Long-Acting Injectable Antipsychotics Cut Readmission for Schizophrenia
Reduction in 30-day readmission rate seen for schizophrenia or schizoaffective disorder with long-acting versus oral antipsychotics
Severe QT Prolongation Common in Users of Antipsychotic Medications
In a recent study, severe QT prolongation occurred in 13.0 percent of quetiapine and 14.2 percent of haloperidol users
Many With Psychosis Have Long-Term Functional Morbidity
Researchers found that few individuals with psychotic disorders have participated in vocational training
ED Visits for Schizophrenia Spectrum Disorders Up After Pandemic Onset
74.9 additional visits for schizophrenia spectrum disorders seen at three months after initial phase of COVID-19 pandemic
Brain Stimulation Can Improve Prospective Memory in Schizophrenia
Twenty transcranial magnetic stimulation treatments over four weeks result in improvement in event-based prospective memory
Psychiatric Comorbidity Increases Risk for Schizophrenia With ADHD
Findings show dose-response relationship, with highest risk for autism, intellectual disability, tic disorder, depression, biopolar disorder
